Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.
about
KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia.High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia.Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia.
P2860
Low NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Low NKD1 expression predicts a ...... normal acute myeloid leukemia.
@en
type
label
Low NKD1 expression predicts a ...... normal acute myeloid leukemia.
@en
prefLabel
Low NKD1 expression predicts a ...... normal acute myeloid leukemia.
@en
P2093
P2860
P356
P1433
P1476
Low NKD1 expression predicts a ...... normal acute myeloid leukemia.
@en
P2093
Dong-Ming Yao
Gao-Fei Xiao
Jing-Dong Zhou
Ting-Juan Zhang
P2860
P304
1010428317699123
P356
10.1177/1010428317699123
P577
2017-04-01T00:00:00Z